Xenon Pharmaceuticals Inc. total revenue, net income and dynamics of changes in Euro today
Xenon Pharmaceuticals Inc. current income in Euro. The dynamics of Xenon Pharmaceuticals Inc. net revenue has changed by -2 140 000 € over the last period. Net income Xenon Pharmaceuticals Inc. - -22 109 000 €. Information about net income is used from open sources. Graph of finance company Xenon Pharmaceuticals Inc.. The financial report chart shows the values from 31/12/2018 to 30/06/2021. A graph of the value of all Xenon Pharmaceuticals Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
2 059 335.37 €
-
-20 527 432.69 €
-
31/03/2021
4 046 250.47 €
-
-14 636 322.26 €
-
31/12/2020
4 781 594.75 €
-
-11 441 474.20 €
-
30/09/2020
6 085 159.61 €
+87.26 % ↑
-8 221 557.58 €
-
30/09/2019
3 249 627.50 €
-
-8 236 413.02 €
-
30/06/2019
0 €
-
-9 291 149.26 €
-
31/03/2019
0 €
-
-10 529 721.57 €
-
31/12/2018
0 €
-
-7 945 803.47 €
-
Show:
to
Xenon Pharmaceuticals Inc. financial report charts
The latest dates of Xenon Pharmaceuticals Inc. financial statements available online: 31/12/2018, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Xenon Pharmaceuticals Inc. is 30/06/2021. Gross profit Xenon Pharmaceuticals Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Xenon Pharmaceuticals Inc. is -16 159 000 €
Xenon Pharmaceuticals Inc. quarterly report dates
Cost of revenue Xenon Pharmaceuticals Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Xenon Pharmaceuticals Inc. is 18 377 000 € Total revenue Xenon Pharmaceuticals Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Xenon Pharmaceuticals Inc. is 2 218 000 € Operating income Xenon Pharmaceuticals Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Xenon Pharmaceuticals Inc. is -22 498 000 €
Net income Xenon Pharmaceuticals Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Xenon Pharmaceuticals Inc. is -22 109 000 € Current assets Xenon Pharmaceuticals Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Xenon Pharmaceuticals Inc. is 266 755 000 € Total assets Xenon Pharmaceuticals Inc. refers to the total amount of assets owned by a person or entity. Total assets Xenon Pharmaceuticals Inc. is 274 711 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-15 003 065.94 €
-11 095 156.75 €
-9 114 740.91 €
-6 026 666.32 €
-5 803 834.72 €
-7 618 055.33 €
-8 483 384.71 €
-5 947 746.79 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
17 062 401.31 €
15 141 407.22 €
13 896 335.66 €
12 111 825.93 €
9 053 462.22 €
7 618 055.33 €
8 483 384.71 €
5 947 746.79 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 059 335.37 €
4 046 250.47 €
4 781 594.75 €
6 085 159.61 €
3 249 627.50 €
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-20 888 605.57 €
-14 910 219.44 €
-11 998 553.20 €
-9 005 182.04 €
-8 310 690.22 €
-9 760 024.08 €
-10 916 891.47 €
-7 830 673.81 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-20 527 432.69 €
-14 636 322.26 €
-11 441 474.20 €
-8 221 557.58 €
-8 236 413.02 €
-9 291 149.26 €
-10 529 721.57 €
-7 945 803.47 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
9 053 462.22 €
9 053 462.22 €
8 483 384.71 €
21 943 341.81 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
22 947 940.94 €
18 956 469.91 €
16 780 147.95 €
15 090 341.65 €
11 560 317.72 €
9 760 024.08 €
10 916 891.47 €
7 830 673.81 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
247 672 681.08 €
262 996 995.90 €
168 779 153.10 €
180 874 266.65 €
89 576 446.27 €
95 933 646.13 €
104 031 717.86 €
112 750 004.21 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
255 059 548.62 €
269 877 850.02 €
175 652 579.49 €
184 883 378.52 €
91 828 902.36 €
98 317 015.78 €
106 355 665.75 €
113 670 113.02 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
76 997 602.45 €
81 690 993.03 €
41 789 281.19 €
14 019 821.50 €
34 976 205.02 €
34 422 839.88 €
48 447 303.70 €
62 907 217.61 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
10 860 255.11 €
8 662 578.45 €
5 919 892.84 €
3 824 347.34 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
22 598 838.10 €
21 452 183.83 €
20 646 276.21 €
17 764 320.85 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
24.61 %
21.82 %
19.41 %
15.63 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
231 420 829.72 €
249 334 633.43 €
151 918 228.70 €
161 823 093.32 €
62 051 172.88 €
69 685 940.58 €
78 530 498.17 €
88 726 900.80 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-6 561 462.16 €
-8 015 438.35 €
-8 047 006.16 €
-6 723 943.53 €
Last revenue report of Xenon Pharmaceuticals Inc. was 30/06/2021. According to last financial report total revenue in Xenon Pharmaceuticals Inc. was 2 059 335.37 Euro and changed by +87.26% since last year. Net income in Xenon Pharmaceuticals Inc. was -20 527 432.69 € in last quartal, net income changes to 0%.
Current cash Xenon Pharmaceuticals Inc. - the sum of all of the cash a company has on the date of report. Current cash Xenon Pharmaceuticals Inc. is 82 930 000 €
Xenon Pharmaceuticals Inc. stocks data
XP0.F stock price
Xenon Pharmaceuticals Inc. stock price today, XP0.F stock quote.
